Citius Oncology Inc.CTORNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Percentile
P0
Near historical low
vs 2Y Ago
-102x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-12.89M-134.7%
2025$-5.49M-4446.7%
2024$126349.00+121.0%
2023$-601300.00-1153.5%
2022$-47970.00-